International Journal of Drug Research and Technology
|
|
- Rudolph Harmon
- 5 years ago
- Views:
Transcription
1 Int. J. Drug Res. Tech. 2012, Vol. 2 (7), ISSN International Journal of Drug Research and Technology Available online at Original Research Paper SCREENING, ANALYSIS TECHNIQUES AND TREATMENT STRATEGIES FOR HAEMOGLOBIN E BETA - THALASSEMIA N. Kanaka Durga Devi*, M. Sai Sree and M. Abhinaya KVSR Siddhartha College of Pharmaceutical Sciences, Vijayawada , Andhra Pradesh ABSTRACT The thalassemia is a diverse group of hereditary disorder in which there is a reduced rate of synthesis of one or more of the globin polypeptide chains. Thus, thalassemia, unlike hemoglobinopathies which are qualitative disorder of the hemoglobin, are quantitative abnormalities of polypeptides globin chain synthesis. Normally an individual inherits two β-globin genes located one each on two chromosomes 11, and two alpha globin genes one each on two chromosome 16, from each parent i.e. normal adult hemoglobin is α 2 β 2. Thalassemias are particularly associated with people of Mediterranean origin, Arabs and Asians. gives the information of a survey in thalassemia center it reveals the information that majority of patients are undergoing blood transfusion when compared to bone marrow transplantation because it is a risky procedure. Gene therapy is an exciting prospect, although, there are still formidable obstacles to be overcome before it is likely to become feasible for the thalassemics. Deliveries of transgenes in stem cell based gene therapy are effective in the therapeutic management. Thalassemias are diverse group of hereditary disorders in which there is a reduced rate of synthesis of one or more of the globin polypeptide chains. Current approaches include hematopoietic stem cell transplantation. Disease management includes prenatal diagnosis, transfusion therapy, bone marrow transplantation out of which only BMT is potentially curative. Keywords: BMT, Gene therapy, Stem cells, Hereditary disorder. INTRODUCTION The thalassemia is a diverse group of hereditary disorder in which there is a reduced rate of synthesis of one or more of the globin polypeptide chains. Thus, thalassemia, unlike hemoglobinopathies which are qualitative disorder of the hemoglobin, are quantitative abnormalities of polypeptides globin chain synthesis. Normally an individual inherits two β- globin genes located one each on two chromosomes 11, and two alpha globin genes one each on two chromosome 16, from each parent i.e. normal adult hemoglobin is α 2 β 2. Thalassemias are particularly associated with people of Mediterranean origin, Arabs and Asians. gives the information of a survey in thalassemia center it reveals the information that majority of patients are undergoing blood transfusion when compared to bone marrow transplantation because it is a risky procedure. Gene therapy is an exciting prospect, although, there are still formidable obstacles to be overcome before it is likely to become feasible for the thalassemics. Deliveries of transgenes in stem cell based gene therapy are effective in the therapeutic management. Thalassemias are diverse group of hereditary disorders in which there is a reduced rate of synthesis of one or more of the globin polypeptide chains. Current approaches include hematopoietic stem cell transplantation. Disease 472
2 management includes prenatal diagnosis, transfusion therapy, bone marrow transplantation out of which only BMT is potentially curative. The thalassemias are classified according to which chain of the hemoglobin molecule is affected. There are two main types of thalassemia. 1-6 Figure1: Statistical data of thalassemia Alpha thalassemia occurs when a gene or genes related to the alpha globin protein are missing or changed (mutated). Beta thalassemia occurs when similar gene defects affect production of the beta globin protein. Signs and Symptoms Severe tissue hypoxia Hemolytic anemia Iron overload Shortness of breath Bone deformities in the face Dark urine Slowed growth and delayed puberty Jaundice An enlarged spleen, liver, and heart Figure2: Pathogenesis of thalassemia 473
3 Molecular Pathogenesis Each hemoglobin molecule contains four subunit proteins. Two of the subunit proteins are called alpha and two are called beta. Hemoglobin properly binds and releases oxygen only when two alpha subunits are connected to two beta subunits. 7,8 A pair of genes located on chromosome #16 controls the production of the alpha subunits of hemoglobin. A single gene located on chromosome #11 controls the production of the hemoglobin beta subunit. Thalassemia occurs when one or more of the genes fail to produce protein, leading to a shortage of one of the subunits. Figure3: Molecular pathogenesis α-thalassemia These are disorders in which there is defective synthesis of α-globin chains 9 resulting in depressed production of hemoglobin that contains alpha chains i.e. HbA, HbA 2 and HbF. Accordingly, alpha thalassemias are classified into four types Hb bar's hydrops foetalis HbH disease: α-thalassemia trait α-thalassemia trait (carrier) β-thalassemia A defect in the production of beta globin protein from the beta genes is the most common cause of beta thalassemia. Most of β-thalassemias arise from different types of mutations10,11 of β- globin gene resulting from single base changes. Depending on the extent of reduction in β-chain synthesis, there are three types of β-thalassemia: Treatment and Management Conventional Treatment Blood Transfusion Iron Chelation Treatment of Complication Cure Infections Heart Failure etc. Bone Marrow and Stem Cells Transplantation Gene Therapy Blood Transfusion Therapy Regular blood transfusion program must be provided for those suffering anemia problems 12 from severe beta-thalassemia diseases. The goal of transfusion therapy is to correct anemia adequate to maintain quality of life and normal development, suppress erythropoiesis and inhibit gastrointestinal iron absorption. The effectiveness of transfusion therapy should be monitored by recording the patient s body weight, pre- and post-transfusion Hb and volume of blood units transfused and the transfusion interval Iron Chelation Therapy The most profound adverse effect of regular blood transfusion 13,14 is iron overload. To prevent continued accumulation of iron in tissues, iron 474
4 chelators need to be administered to facilitate removal of iron through faecal and urinary routes. Bone Marrow Transplantation (Hematopoietic Stem Cell Transplantation) Figure4: Survival rate of HSC transplantation This modern procedure has been the only accepted method worldwide to cure β-thalassemia diseases by means of allograft transplantation. The major source of haematopoietic stem cells for transplant is still derived from HLA-identical sibling bone marrow. A blood and marrow stem cell transplant replaces faulty stem cells with healthy ones from another person. 15 Treating complications An important part of managing thalassemias is treating complications treatment 16 may be needed for heart or liver diseases, infections, osteoporosis, and other health problems. Gene Replacement Therapy The transfer of a globin gene in autologous haematopoietic stem cells is an attractive treatment possibility. It poses challenges in terms of controlling transgene expression, which should be: Erythroid-specific Elevated Position-independent Sustained over time. Gene transfer using onco-retroviral vectors: Figure5: Gene transfer by retro viral vectors Recombinant onco-retroviruses were the first viral vectors used to transfer the human β-globin gene in mouse HSCs. Studies aimed at increasing expression 17,18 levels of transferred β-globin genes have focused on locus control region elements of the human β-globin gene locus into 475
5 onco-retroviral vectors. Incorporation of the core elements of HS2, HS3, and HS4 of the human β- globin LCR significantly increased expression Gene transfer using lentiviral vectors levels in murine erythroleukemia (MEL) cells but failed to abolish positional variability of expression. Lentiviral vectors which stably transmit the β - globin expression cassette, offering new prospects for the manipulation of haemopoietic stem. The Lentiglobin vector is self inactivating and contains large elements of the b-globin locus control region as well as chromatin insulators and other features that should prevent untoward events. The original studies in mice showed that lentiviral-mediated human β-globin gene transfer can rescue mice affected by β-thalassemia intermedia and β-thalassemia major. Gene correction and induced pluripotent stem (ips) cells 19 The only cells that are amenable to gene targeting and correction, which requires unlimited in vitro cell division without losing multipotency, are the embryonic stem cells. Cells obtained by this reverse-differentiation process, called induced pluripotent stem cells. Subsequently, the ips cells were differentiated into hematopoietic cells that synthesized hemoglobin. Therefore, in the future the mutation in the β-globin gene of these ips cells could be corrected by gene targeting Splice-switching and stop codon readthrough 20 Defective β-globin gene expression and β-globin deficiency can be attributed to almost 200 Figure6: Schematic representation of gene therapy thalassemic mutations. These mutations lead to incorrectly spliced mrnas, even though the correct splice sites remain undamaged and potentially functional. Use of small nuclear RNA and splice-switching oligo-nucleotides can restore the corrected splicing re-establishing the synthesis of the normal protein. Another approach showing a great potential for the treatment of genetic disorders characterized by to premature termination codons is the use of drugs to induce stop codon readthrough. These modified RNA would protect against nonsense-mediated mrna decay and allow production of a protein. RESULT AND DISCUSSION Figure 1 gives the Statistical data of thalassemia where the affected people are higher in Arab countries. Figure 2 illustrate the pathogenesis of thalassemia where as Figure 3 gives the details of molecular pathogenesis of thalassemia. In Figure 4 the rate of survival of patients after bone marrow transplantation. As the graph gives the survival rate as it is a risky procedure to get a HLA- identical sibling bone marrow. Figure 5 give the information of gene transfer using retro viral vectors. Figure 6 shows the schematic representation of gene therapy
6 REFERENCES 1. Boulad, F; Giardina, P; Gillio, A; Kernan, N; Small, T and Brochstein, J, et al. (1998), Bone marrow transplantation for homozygous betathalassemia, The Memorial Sloan-Kettering Cancer Center experience, Ann N Y Acad Sci,850, Caterina, Borgna-Pignatt (2007), Modern treatment of thalassaemia intermedia, The above Figure gives the information of a survey in thalassemia center it reveals the information that majority of patients are undergoing blood transfusion when compared to bone marrow transplantation because it is a risky procedure. Despite the increased life expectancy of thalassemia, complications keep arising. These relate to inadequate trans-fusions, transfusion transmitted viral diseases, allo-sensitization, iron overload related endocrine, liver and cardiac disturbances as well as toxicities of iron chelators. Gene therapy is an exciting prospect, although, there are still formidable obstacles to be overcome before it is likely to become feasible for the thalassemics. Deliveries of transgenes in stem cell based gene therapy are effective in the therapeutic management. Lentiviral vectors have an advantage over onco-retroviral vector due to integration of larger element and minimal sequence rearrangement. Induced pluripotent stem cells, splice-switching and stop codon readthrough are other genetic approaches which are showing advantages over the current therapy. CONCLUSION Thalassemias are diverse group of hereditary disorders in which there is a reduced rate of synthesis of one or more of the globin polypeptide chains. Current approaches include hematopoietic stem cell transplantation. Disease management includes prenatal diagnosis, transfusion therapy, bone marrow transplantation; out of which only BMT is potentially curative. As thalassemia is genetically derived disorder, genetic and cellular targets are potential approaches in management of disease. ACKNOWLEDGEMENT The authors are very much thankful to Management and principal of KVSR Siddhartha College of pharmaceutical sciences, Vijayawada for their support and constant encouragement. British Journal of Haematology,138, MB, Agarwal (2004), Advances in management of thalassemia, Indian Pediatrics,41, Paolo, Moi and Michel, Sadelain (2008), Towards the genetic treatment of β - thalassemia: new disease models, new vectors, new cells, Haematologica, 93 (3),
7 5. Raja, JV; Rachchh, MA and Gokani, RH (2012), Recent advances in gene therapy for thalassemia, J Pharm Bioall Sci, 4, Sadelain, M; Wang, CH; Antoniou, M; Grosveld, F and Mulligan, RC (1995), Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene, Proc Natl Acad Sci USA, 92, Vichinsky, E; Levine, L and Bhatia, S et al. (2008), Standards of Care Guidelines for Thalassemia, Children s Hospital & Research Center Oakland, U.S.A. 8. SL, Schrier (2002), Pathophysiology of Thalassemia, Curr. Opin. Hematol., 2, DJ, Weathedrall and JB, Clegg (2001), The Thalassemia Syndromes, 4 th Ed., Blackwell Scientific Publications, Oxford. 10. K, Indrak; YJ, Fei and HW, Li et al.(1991), A Czechoslovakian teenager with Hb E-beta zerothalassemia complicated by the presence of an alpha-globin gene triplication, Ann. Hematol., 63 (1), DJ, Weatherall (2001), Phenotype genotype relationships in monogenic disease: lessons from the thalassaemias, Nat. Rev. Genet., 2 (4), AJ, Kihm; Y, Kong and W, Hong et al.(2002), An abundant erythroid protein that stabilizes free alpha hemoglobin, Nature, 417 (6890), D.,Gell; Y, Kong and SA, Eaton et al.(2002), Biophysical characterization of the alpha-globin binding protein alpha-hemoglobin stabilizing protein, J. Biol. Chem., 277 (43), Y, Kong; S, Zhou anf AJ, Kihm, et al.(2004), Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia, J. Clin. Invest., 114 (10), MI, Lai; J, Jiang and N, Silver et al. (2006), Alpha-haemoglobin stabilising protein is auantitative trait gene that modifies the phenotype of beta-thalassaemia, Br. J.Haematol., 133 (6), R, Galanello; L, Perseu and N, Giagu et al. (2003), AHSP expression in betathalassemiacarriers with thalassemia intermedia phenotype, Blood, 102, V, Viprakasit; VS, Tanphaichitr and W, Chinchang et al. (2004), Evaluation of alphahemoglobin stabilizing protein (AHSP) as a genetic modifier in patients withbeta thalassemia, Blood, 103 (9), JZ, Zhang; XM, Xu and WF, Ma et al.(1994), Reverse dot blot analysis: a rapid prenataldiagnostic approach for β- thalassemia mutations in Chinese, Chin. Sci. Bull., 39, XM, Xu; YQ, Zhou and GX, Luo et al. (2004), The prevalence and spectrum of alpha and betathalassaemia in Guangdong Province: implications for the future health burdenand population screening, J. Clin. Pathol., 57 (5), V, Chan, I, Yam and FE, Chen et al. (1999), A reverse dot-blot method for rapid detection ofnon-deletion alpha thalassaemia, Br. J. Haematol., 104 (3),
In adults, the predominant Hb (HbA) molecule has four chains: two α and two β chains. In thalassemias, the synthesis of either the α or the β chains
Thalassaemias Thalassemia Thalassemia is an inherited autosomal recessive blood disease. Associated with absence or reduction in a or b globin chains. Reduced synthesis of one of the globin chains can
More informationThalassemias:general aspects and molecular pathology
Thalassemias:general aspects and molecular pathology Prof. Renzo Galanello Pediatric Clinic 2 University of Cagliari Ospedale Regionale Microcitemie-ASL8 HEMOGLOBINOPATHIES CLASSIFICATION Structurally
More informationThalassemia Maria Luz Uy del Rosario, M.D.
Thalassemia Maria Luz Uy del Rosario, M.D. Philippine Society of Hematology and Blood Transfusion Philippine Society of Pediatric Oncology What is Thalassemia Hereditary Hemoglobin disorder Hemolytic anemia
More informationAn overview of Thalassaemias and Complications
An overview of Thalassaemias and Complications Haemoglobin Haemoglobin is the most abundant protein in blood, and exists as three main types in normal adults: HbA ( ) - 97% HbA 2 ( ) - 2.5% HbF ( ) - 0.5%
More informationSICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN
SICKLE CELL DISEASE Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN Objective: The student should be able: To identify the presentation, diagnosis,
More informationDr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan,
Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan, KSA amashi@moh.gov.sa 24/02/2018 β-thalassemia syndromes
More informationHaemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD
Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD Introduction is the iron-containing oxygen transport metalloprotein in the red blood cells Hemoglobin in the blood carries oxygen from the respiratory organs
More informationThalassemias. Emanuela Veras, M.D. 01/08/2006
Thalassemias Emanuela Veras, M.D. 01/08/2006 Structure and Function of normal Hemoglobin molecules: 2/3 1/3 β: increases from 6 th week of fetal life to 12 months of age At birth: HbF: 75-90% HbA: 10-25%
More informationTHALASSEMIA AND COMPREHENSIVE CARE
1 THALASSEMIA AND COMPREHENSIVE CARE Melanie Kirby MBBS, FRCP (C), Hospital for Sick Children, Toronto Associate Professor of Paediatrics, University of Toronto. Objectives 2 By the end of this presentation,
More informationComprehensive Hemoglobin Analysis HBA1/2 (
Comprehensive Hemoglobin Analysis HBA1/2 ( α-globin) and HBB (β-globin) mutation and deletion/duplication analysis and HBD (δ-globin) and HBG1/2 (γ-globin) mutation analysis Description: Hemoglobin (Hb)
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Alpha Thalassemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_alpha_thalassemia 9/2013 7/2017 7/2018 7/2017 Description
More informationGenetics of Thalassemia
Genetics of Thalassemia Submitted by : Raya Samir Al- Hayaly Sura Zuhair Salih Saad Ghassan Al- Dulaimy Saad Farouq Kassir Sama Naal Salouha Zahraa Jasim Al- Aarajy Supervised by : Dr. Kawkab Adris Mahmod
More informationThe Beats of Natural Sciences Issue 3-4 (September-December) Vol. 3 (2016)
Frequency of β (Beta Thalassaemia) Trait and Haemaglobin E (HbE) Trait: Case Study in a Thalassaemia Carrier Detection Camp in Gurudas College, West Bengal, India Mitu De Department of Botany, Gurudas
More informationTransfusion support in Thalassaemia. Dr.A.keerti 1 st year PG DEPT. OF TRANSFUSION MEDICINE
Transfusion support in Thalassaemia Dr.A.keerti 1 st year PG DEPT. OF TRANSFUSION MEDICINE Structure of hemoglobin Types of hemoglobins Hemoglobin-Development Switching Thalassaemia- introduction Classification
More informationThalassemia. By: Rebecca Chang (Period 6)
+ Thalassemia By: Rebecca Chang (Period 6) + Physiology Ø Two types of thalassemia: alpha and beta Ø Autosomal recessive inheritance pattern Ø Hemoglobin is damaged but symptoms greatly vary, especially
More informationThe Thalassemias in Clinical Practice. Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland
The Thalassemias in Clinical Practice Ashutosh Lal, MD Director Comprehensive Thalassemia Program UCSF Benioff Children s Hospital Oakland Outline Thalassemia: definitions and pathophysiology Epidemiology
More informationHaemoglobinophaties EBMT 2011 Data Manager session
Haemoglobinophaties EBMT 2011 Data Manager session Presentation plan Biological characteristics Clinical characteristics Transplant resuts What is different From transplant in malignancies Between Thalassemia
More informationThe Nucleated Red Blood Cell (NRBC) Count in Thalassaemia Syndromes Paolo Danise and Giovanni Amendola
7. The Nucleated Red The Nucleated Red Blood Cell (NRBC) Count in Thalassaemia Syndromes Paolo Danise and Giovanni Amendola Introduction The purpose of this study was to evaluate the performance of the
More informationPreface: Thalassemia Bernard G. Forget
Thalassemia Preface: Thalassemia Bernard G. Forget xiii Thalassemia: An Overview of 50 Years of Clinical Research 1005 Vijay G. Sankaran and David G. Nathan The thalassemias are attributable to the defective
More informationGeorge R. Honig Junius G. Adams III. Human Hemoglobin. Genetics. Springer-Verlag Wien New York
George R. Honig Junius G. Adams III Human Hemoglobin Genetics Springer-Verlag Wien New York George R. Honig, M.D., Ph.D. Professor and Head Department of Pediatrics, College of Medicine University of Illinois
More information4 Jumana Jihad Dr. Ahmad Mansour Dr. Ahmad Mansour
4 Jumana Jihad Dr. Ahmad Mansour Dr. Ahmad Mansour Anemia Decreased blood production Increased blood loss Hemolytic Hemorrhage Extravascular Intravascular Hemolytic (Further classification( Extrinsic Intrinsic
More informationG.Madhu Latha et al., Asian Journal of Pharmaceutical Technology & Innovation, 02 (08); 2014; Review Article
Asian Journal of Pharmaceutical Technology & Innovation ISSN: 2347-8810 Review Article Received on: 29-07-2014 Accepted on: 19-08-2014 Published on: 15-10-2014 A New Era in Thalassemia Disorder: An Overview
More informationBeta Thalassemia Frequency in Bahrain: A Ten Year Study. Shaikha Salim Al-Arrayed, MB,ChB, DHCG, PhD*
Bahrain Medical Bulletin, Vol. 2, No. 2, June 200 Beta Thalassemia Frequency in Bahrain: A Ten Year Study Shaikha Salim Al-Arrayed, MB,ChB, DHCG, PhD* Background: Sickle-cell disease and Thalassanemia
More informationHemoglobinopathies Diagnosis and management
Hemoglobinopathies Diagnosis and management Morgan L. McLemore, M.D. Hematology/Leukemia Department of Hematology and Oncology Winship Cancer Institute at Emory University mlmclem@emory.edu Disclosures
More informationHemolytic anemias (2 of 2)
Hemolytic anemias (2 of 2) Sickle Cell Anemia The most common familial hemolytic anemia in the world Sickle cell anemia is the prototypical (and most prevalent) hemoglobinopathy Mutation in the β-globin
More informationGenetic Modulation on the Phenotypic Diversity of Sickle Cell Disease
Genetic Modulation on the Phenotypic Diversity of Sickle Cell Disease Malay B. Mukherjee Abstract Sickle cell hemoglobin is a β chain structural variant where valine is substituted for glutamic acid in
More informationA group of inherited disorders characterized by reduced or absent amounts of hemoglobin, the oxygencarrying protein inside the red blood cells.
Thalassemia A group of inherited disorders characterized by reduced or absent amounts of hemoglobin, the oxygencarrying protein inside the red blood cells. Types of Thallasemia 1) Thalassemia trait 2)
More informationHow to Write a Life Care Plan for a Child with Hemoglobinopathy
How to Write a Life Care Plan for a Child with Hemoglobinopathy Tamar Fleischer, BSN, MSN, CNLCP & Mona Yudkoff, RN, MPH, CRRN, CNLCP BalaCare Solutions March 2018 St. Peterburg, Florida What is Hemoglobinopathy?
More informationClinical Characteristics of Pediatric Thalassemia in Korea: A Single Institute Experience
ORIGINAL ARTICLE Pediatrics http://dx.doi.org/10.3346/jkms.2013.28.11.1645 J Korean Med Sci 2013; 28: 1645-1649 Clinical Characteristics of Pediatric Thalassemia in Korea: A Single Institute Experience
More informationBeta Thalassemia Case Study Introduction to Bioinformatics
Beta Thalassemia Case Study Sami Khuri Department of Computer Science San José State University San José, California, USA sami.khuri@sjsu.edu www.cs.sjsu.edu/faculty/khuri Outline v Hemoglobin v Alpha
More informationHematologic Features of Alpha Thalassemia Carriers
IJMCM Summer 2012, Vol 1, No 3 Original Article Hematologic Features of Alpha Thalassemia Carriers Haleh Akhavan-Niaki 1,2, Reza Youssefi Kamangari 2, Ali Banihashemi 2, Vahid Kholghi Oskooei 1, Mandana
More informationCRISPR-mediated Editing of Hematopoietic Stem Cells for the Treatment of β-hemoglobinopathies
CRISPR-mediated Editing of Hematopoietic Stem Cells for the Treatment of β-hemoglobinopathies Jennifer Gori American Society of Gene & Cell Therapy May 11, 2017 editasmedicine.com 1 Highlights Developed
More informationAnemia s. Troy Lund MSMS PhD MD
Anemia s Troy Lund MSMS PhD MD lundx072@umn.edu Hemoglobinopathy/Anemia IOM take home points. 1. How do we identify the condtion? Smear, CBC Solubility Test (SCD) 2. How does it present clincally? 3. How
More informationFetal Anemia 02/13/13. Anjulika Chawla, M.D. Assistant Professor Division of Pediatric Hematology/Oncology
Fetal Anemia 02/13/13 Anjulika Chawla, M.D. Assistant Professor Division of Pediatric Hematology/Oncology Objectives Definition of anemia Diagnosis of fetal anemia Normal developmental hematopoiesis Etiology
More informationEducational Items Section
Atlas of Genetics and Cytogenetics in Oncology and Haematology OPEN ACCESS JOURNAL AT INIST-CNRS Educational Items Section Hemoglobin genes; Sickle-cell anemia - Thalassemias Jean-Loup Huret, Xavier Troussard
More informationExtra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.
Extra Notes 3 *The numbers of the slides are according to the last year slides. Slide 33 Autoimmune hemolytic anemia : Abnormal circulating antibodies that target normal antigen on the RBC and cause lysis.
More informationDisclosures of: Emanuele Angelucci
Company name Novartis Disclosures of: Emanuele Angelucci Research support Employee Consultant Stockholder Speakers bureau Advisory board Chair of TELESTO pro Other EBMT 2012 Educational Session Haemoglobinopathy
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/1887/35456 holds various files of this Leiden University dissertation. Author: Hassan, Suha Mustafa Title: Toward prevention of Hemoglobinopathies in Oman Issue
More informationChanges in hematological parameters in α-thalassemia individuals co-inherited with erythroid Krüppel-like factor mutations
Clin Genet 2015: 88: 56 61 Printed in Singapore. All rights reserved Short Report 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12443 Changes in hematological
More informationDr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW
Dr Banu Kaya Consultant Haematologist Barts Health NHS Trust Royal London Hospital, London, UK SICKLE CELL AND THALASSAEMIA OVERVIEW Objectives Gain awareness of haemoglobinopathy inheritance, pathophysiology
More informationDONE BY : RaSHA RAKAN & Bushra Saleem
DONE BY : RaSHA RAKAN & Bushra Saleem Hemolytic anemias (2 of 2) Sickle Cell Anemia The most common familial hemolytic anemia in the world Sickle cell anemia is the prototypical (and most prevalent) hemoglobinopathy
More informationEpidemiological Study among Thalassemia Intermedia Pediatric Patients
Med. J. Cairo Univ., Vol. 78, No. 2, December 651-655, 2010 www.medicaljournalofcairouniversity.com Epidemiological Study among Thalassemia Intermedia Pediatric Patients NERMEEN KADDAH, M.D.; KHALED SALAMA,
More informationChem*3560 Lecture 4: Inherited modifications in hemoglobin
Chem*3560 Lecture 4: Inherited modifications in hemoglobin Genetic modifications fall into two classes: Thalassemias, which are the result of failure to express globin genes. Thalassa is Greek for the
More informationA s one of inherited disorders of haemoglobin (Hb)
517 ORIGINAL ARTICLE The prevalence and spectrum of a and b thalassaemia in Guangdong Province: implications for the future health burden and population screening X M Xu, Y Q Zhou, G X Luo, C Liao, M Zhou,
More informationArticle Preimplantation diagnosis and HLA typing for haemoglobin disorders
RBMOnline - Vol 11. No 3. 2005 362-370 Reproductive BioMedicine Online; www.rbmonline.com/article/1853 on web 20 July 2005 Article Preimplantation diagnosis and HLA typing for haemoglobin disorders Dr
More informationHypochromic Anaemias
Hypochromic Anaemias Dr Mere Kende MBBS, MMED (Path), MAACB, MACTM, MACRRM LECTURER-SMHS Anaemia LOW HEMOGLOBIN Anaemia Definition: Hb
More informationHAEMOGLOBINOPATHIES. Editing file. References: 436 girls & boys slides 435 teamwork slides. Color code: Important. Extra.
HAEMOGLOBINOPATHIES Objectives: normal structure and function of haemoglobin. how the globin components of haemoglobin change during development, and postnatally. the mechanisms by which the thalassaemias
More informationPOLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS BENEFIT VARIATIONS DISCLAIMER CODING INFORMATION REFERENCES POLICY HISTORY
Original Issue Date (Created): November 26, 2013 Most Recent Review Date (Revised): November 26, 2013 Effective Date: April 1, 2014 POLICY PRODUCT VARIATIONS DESCRIPTION/BACKGROUND RATIONALE DEFINITIONS
More informationDiagnostic difficulties in prevention and control program for thalassemia in Thailand: atypical thalassemia carriers
Diagnostic difficulties in prevention and control program for thalassemia in Thailand: atypical thalassemia carriers Pranee Winichagoon Fucharoen Thalassemia Research Center Institute of Molecular Biosciences
More informationCongenital Haemoglobinopathies
Congenital Haemoglobinopathies L. DEDEKEN, MD H O P I T A L U N I V E R S I T A I R E D E S E N F A N T S R E I N E F A B I O L A U N I V E R S I T E L I B R E DE B R U X E L L E S Red Blood Cell Disorders
More informationJournal of Medical Science & Technology
Page82 Original Article Journal of Medical Science & Technology Open Access Screening for hemoglobinopathies among patients in a government hospital and health clinics in Perlis, Malaysia Chin Yuet Meng
More informationGamma gene expression in haemoglobin disorders
Gamma gene expression in haemoglobin disorders Innovative therapies for Red Cell and Iron related disorders EHA / ESH : April 16-18, Cascais, Portugal Swee Lay Thein King s College London School of Medicine
More informationHaemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference October 2017
Haemoglobinopathies case studies 11 th Annual Sickle Cell and Thalassaemia Conference 11 13 October 2017 Chris Lambert Haematology Service Delivery Manager Viapath Laboratories Kings College Hospital HUMAN
More informationHemoglobinopathy. Pathophysiology of β Thalassemia A Guide to Molecular Therapies. Swee Lay Thein
Hemoglobinopathy Session Chair: George Stamatoyannopoulos, MD, DrSci Speakers: Swee Lay Thein, MD, FRCP, FRCPath, DrSci; Susan P. Perrine, MD; and Philippe Leboulch, MD Pathophysiology of β Thalassemia
More informationClinical Policy: Allogenic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-thalassemia
Clinical Policy: Allogenic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-thalassemia Reference Number: CP.MP.108 Effective Date: 03/16 Last Review Date: 03/17 See Important Reminder at the
More informationEpidemiology, Care and Prevention of Hemoglobinopathies
Epidemiology, Care and Prevention of Hemoglobinopathies Nasir Al-Allawi MBChB, PhD. Professor of Hematology College of Medicine University of Dohuk, IRAQ From Research to Practice Training Course in Sexual
More informationSickle cell disease. Fareed Omar 10 March 2018
Sickle cell disease Fareed Omar 10 March 2018 Physiology Haemoglobin structure HbA2: 2α and 2δ chains (2-3%) HbF: 2α and 2γ chains (
More informationEvaluation of Cardiac Complications in Patients with Thalassemia Major Using Serum Ferritin Levels
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijssJuneI/2017/016 Evaluation of Cardiac Complications in Patients with Thalassemia Major Using Serum Ferritin Levels Farideh
More informationWhen do you have to perform the molecular biology in the hemoglobinopathies diagnosis
When do you have to perform the molecular biology in the hemoglobinopathies diagnosis Maria Domenica Cappellini MD, FRCP;FACP Fondazione Ca Granda Policlinico IRCCS University of Milan Disclosure Member
More informationBeta-thalassemia:clinical findings,molecular defects and genotype/phenotype relationships
Beta-thalassemia:clinical findings,molecular defects and genotype/phenotype relationships Maria Domenica Cappellini Fondazione Ca Granda Policlinico IRCCS University of Milan Disclosure Member of Advisory
More informationPrevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario A Prospective Cohort Study
Hematopathology / PREVALENCE OF THALASSEMIA IN ONTARIO Prevalence of Thalassemia in Patients With Microcytosis Referred for Hemoglobinopathy Investigation in Ontario A Prospective Cohort Study John D.
More information6.1 Extended family screening
CHAPTER 6 CONCLUSION Cost benefit analysis of thalassemia screening programs have shown that the single years treatment for a β-thalassemia major patient was much higher than a total cost per case prevented.
More informationHaemoglobinopathy Case Studies. Dr Jill Finlayson Department of Haematology Pathwest Laboratory Medicine
Haemoglobinopathy Case Studies Dr Jill Finlayson Department of Haematology Pathwest Laboratory Medicine Case 1 KB, 36y M Refugee Afghanistan Screening bloods Hb 101 g/l RCC 3.75 x10 12 /L MCV 90 fl MCH
More informationQuiz. What percentage of the world s population is a carrier of a hemoglobinopathy? Hemoglobinopathies in Pregnancy 1-2% 5-7% 8-12% 10-15%
Hemoglobinopathies in Pregnancy Emily Parkhurst, MS, LCGC Kaiser West Los Angeles November 2017 Genetics Department Quiz What percentage of the world s population is a carrier of a hemoglobinopathy? 1-2%
More informationPaolo Moi, Italy. Università di Cagliari Ospedale Pediatrico Microcitemico - A. Cao - CAGLIARI
T H E O R E T I C A L A N D P R A C T I C A L T R A I N I N G I N HAEMATOLOGICAL RARE DISEASES: from genetic counselling - through bench - to bed Gene Therapy for Hemoglobinopathies Paolo Moi, Italy Università
More informationAnaemia in Pregnancy
Anaemia in Pregnancy Definition :anaemia is a pathological condition in which the oxygen-carrying capacity of red blood cells is insufficient to meet the body needs. The WHO : haemoglobin concentration
More informationDr.Abdolreza Afrasiabi
Dr.Abdolreza Afrasiabi Thalassemia & Heamophilia Genetic Reaserch Center Shiraz Medical University Hemoglobin tetramer Hemoglobin Structure % A 1 α 2 β 2 94-97% A 2 α 2 δ 2 2.5% A 1C α 2 (β-n-glucose)
More informationReport of Beta Thalassemia in Newar Ethnicity
Report of Beta Thalassemia in Newar Ethnicity Rajendra Dev Bhatt 1*, Surendra Koju 2, Prabodh Risal 1 Affiliations: 1 Department of Clinical Biochemistry, Dhulikhel Hospital, Kathmandu University Hospital
More informationRBCs Disorders 2. Dr. Nabila Hamdi MD, PhD
RBCs Disorders 2 Dr. Nabila Hamdi MD, PhD ILOs Discuss the classification of anemia into hypochromic-microcytic, normochromicnormocytic and macrocytic. Categorize laboratory test procedures used in the
More informationResearch Article Clinical Features and Molecular Analysis of Hb H Disease in Taiwan
BioMed Research International, Article ID 271070, 5 pages http://dx.doi.org/10.1155/2014/271070 Research Article Clinical Features and Molecular Analysis of Hb H Disease in Taiwan Yu-Hua Chao, 1,2,3 Kang-Hsi
More informationBiology 2C03: Genetics What is a Gene?
Biology 2C03: Genetics What is a Gene? September 9 th, 2013 Model Organisms - E. coli - Yeast - Worms - Arabodopsis - Fruitflie - Mouse What is a Gene? - Define, recognize, describe and apply Mendel s
More informationLecture 5. Dr. Sameh Sarray Hlaoui
Lecture 5 Myoglobin & Hemoglobin Dr. Sameh Sarray Hlaoui Myoglobin and Hemoglobin Myoglobin - Myoglobin and Hemoglobin are (metalloprotein containing a heme prosthetic group). hemeproteins - Function as
More informationGenes and Genetic Diseases. Gene: Is a fundamental unit of information storage.
GENETIC DISORDERS Genes and Genetic Diseases Gene: Is a fundamental unit of information storage. Genes determine the type of proteins and enzymes that are made by the cell. Genes control inheritance and
More informationJMSCR Vol 05 Issue 11 Page November 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 71.58 ISSN (e)-2347-176x ISSN (p) 2455-45 DOI: https://dx.doi.org/1.18535/jmscr/v5i11.16 Assessment of Serum Ferritin, Vitamin B12
More informationdb-thalassemia Patients With Homozygous Xmn-1 Polymorphism That Are Characterized By A Milder Phenotype
ISPUB.COM The Internet Journal of Hematology Volume 7 Number 2 db-thalassemia Patients With Homozygous Xmn-1 Polymorphism That Are Characterized By A Milder S Ashraf Citation S Ashraf. db-thalassemia Patients
More informationMOLECULAR BASIS OF THALASSEMIA IN SLOVENIA
MOLECULAR BASIS OF THALASSEMIA IN SLOVENIA Dijana Plaseska-Karanfilska, MD, PhD Research Centre for Genetic Engineering and Biotechnology Georgi D. Efremov, Macedonian Academy of Sciences and Arts, Skopje,
More informationThalassemia intermedia in HbH-CS disease with compound heterozygosity for β-thalassemia: Challenges in hemoglobin analysis and clinical diagnosis
Genes Genet. Syst. (2009) 84, p. 67 71 Thalassemia intermedia in HbH-CS disease with compound heterozygosity for β-thalassemia: Challenges in hemoglobin analysis and clinical diagnosis Jin Ai Mary Anne
More informationRed cell disorder. Dr. Ahmed Hasan
Red cell disorder Dr. Ahmed Hasan Things to be learned in this lecture Definition and clinical feature of anemia. Classification of anemia. Know some details of microcytic anemia Question of the lecture:
More informationJournal of Chemical and Pharmaceutical Research, 2015, 7(6): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2015, 7(6):568-572 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 Early markers of renal dysfunction in Syrian beta
More informationBeta Thalassemia Sami Khuri Department of Computer Science San José State University Spring 2015
Bioinformatics in Medical Product Development SMPD 287 Three Beta Thalassemia Sami Khuri Department of Computer Science San José State University Hemoglobin Outline Anatomy of a gene Hemoglobinopathies
More informationHematopathology / SCREENING FOR THE (-- SEA ) ALPHA 0 -THALASSEMIA DELETION
Hematopathology / SCREENING FOR THE (-- SEA ) ALPHA 0 -THALASSEMIA DELETION A Reliable Screening Test to Identify Adult Carriers of the (-- SEA ) alpha 0 -Thalassemia Deletion Detection of Embryonic zeta-globin
More informationHEMOGLOBINOPATHIES LECTURE OUTLINE. An overview of the structure of hemoglobin. Different types of hemoglobin. Definition of hemoglobinopathies
Slide 1 HEOGLOBINOPATHIES Slide 2 LETURE OUTLINE An overview of the structure of hemoglobin. Different types of hemoglobin. Definition of hemoglobinopathies Sickle ell Disease and Hemoglobin Slide 3 HEOGLOBIN
More informationCHAPTER 15. First human gene therapy trial for haemoglobin disorders
IRON2009_CAP.15(390-401):IRON2009 4-12-2009 16:31 Pagina 390 * CHAPTER 15 First human gene therapy trial for haemoglobin disorders Emmanuel Payen, Olivier Nègre, Beatrix Gillet-Legrand, Yves Beuzard, Eliane
More informationHaemoglobin Lepore in a Malay family: a case report
Malaysian J Pathol 2005; 27(1) : 33 37 HAEMOGLOBIN LEPORE CASE REPORT Haemoglobin Lepore in a Malay family: a case report Josephine PASANGNA MPath, *Elizabeth GEORGE FRCPA, FRCPE and Menaka NAGARATNAM
More informationScreening for haemoglobinopathies in pregnancy
Policy Statement All Southern Health patients will receive clinical care that reflects best practice and is based on the best available evidence. Index of chapters within background 1. Prevalence of haemoglobinopathies
More informationHEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS
Hemolytic Anemia Due to Abnormal Hemoglobin Synthesis MODULE 19 HEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS 19.1 INTRODUCTION There are two main mechanisms by which anaemia is produced (a) Thalassemia:
More informationThe pros and cons of the fourth revision of thalassaemia screening programme in Iran
Original Article The pros and cons of the fourth revision of thalassaemia screening programme in Iran J Med Screen 2017, Vol. 24(1) 1 5! The Author(s) 2016 Reprints and permissions: sagepub.co.uk/journalspermissions.nav
More informationThe diagnosis of Hemoglobinopathies
1ST IFCC, EFLM, AFCB CONFERENCE "LABORATORY MEDICINE: MEETING THE NEEDS OF MEDITERRANEAN NATIONS" Rome, Italy 02/07/2018 The diagnosis of Hemoglobinopathies Dr Antonino Giambona Unit of Hematology of Rare
More informationGenetic Modifiers of Sickle Cell Disease Severity. Kunle Adekile, MD, PhD Professor Department of Pediatrics Kuwait University
Genetic Modifiers of Sickle Cell Disease Severity Kunle Adekile, MD, PhD Professor Department of Pediatrics Kuwait University Outline Hb Molecule and Genetic control of globin synthesis Pathophysiology
More informationFig.No.1. Effect on RBCs
A Review on Thalassemia Debasis Das 1 *, Amartya De 1 1 BCDA College of Pharmacy and Technology,78, Jessore Road (south), Hridaypur, Barasat, Kolkata 700127. India. Corresponding Author: Debasis Das Email:
More informationGene Therapy for Sickle Cell Disease: A Safety/Efficacy Trial
Gene Therapy for Sickle Cell Disease: A Safety/Efficacy Trial Elizabeth Hexner A. Introduction Sickle cell disease (SCD) is an autosomal recessive disease of red blood cells (RBCs). A single amino acid
More informationHigh Hemoglobin F in a Saudi Child Presenting with Pancytopenia
Case Report imedpub Journals http://www.imedpub.com Journal of Pediatric Care ISSN 2471-805X DOI: 10.21767/2471-805X.100002 High Hemoglobin F in a Saudi Child Presenting with Pancytopenia Abstract Saudi
More informationClinical, haematological, and genetic studies of type 2
Journal of Medical Genetics 1988, 25, 195-199 Clinical, haematological, and genetic studies of type 2 normal Hb A2 thalassaemia ANNA METAXOTOU-MAVROMATI, CHRISTOS KATTAMIS, LILIAN MATATHIA, MARIA TZETIS,
More informationEditorial PRESENT STATUS OF HEMOGLOBINOPATHIES IN INDIA
Editorial PRESENT STATUS OF HEMOGLOBINOPATHIES IN INDIA The last decade has witnessed an enormous progress in the field of hemoglobinopathies. This explosion in knowledge came in the wake of advances in
More informationEvaluation of hemoglobinopathy screening results of a six year period in Turkey
Evaluation of hemoglobinopathy screening results of a six year period in Turkey Seçil Gunher Arıca, Ebru Turhan, Cahit Özer, Vefik Arıca, Dilek Benk Şilfeler, Đbrahim Şilfeler, Ayşe Betül Altun Vol. 4
More informationNewborn bloodspot results: predictive value of screen positive test for thalassaemia major
Original Article Newborn bloodspot results: predictive value of screen positive test for thalassaemia major J Med Screen 20(4) 183 187! The Author(s) 2013 Reprints and permissions: sagepub.co.uk/journalspermissions.nav
More informationArticle Stem cell transplantation for thalassaemia
RBMOnline - Vol 10. No 1. 2005 111-115 Reproductive BioMedicine Online; www.rbmonline.com/article/1525 on web 10 November 2004 Article Stem cell transplantation for thalassaemia Dr Javid Gaziev Javid Gaziev
More informationThalassaemia. What is thalassaemia? What causes thalassaemia? What are the different types of thalassaemia?
Thalassaemia Thalassaemia is an inherited condition affecting the blood. There are different types, which vary from a mild condition with no symptoms, to a serious or lifethreatening condition. For the
More informationCOEXISTENCE OF β-thalassemia AND POLYCYTHEMIA VERA: A CHICKEN-AND-EGG DEBATE?
COEXISTENCE OF β-thalassemia AND POLYCYTHEMIA VERA: A CHICKEN-AND-EGG DEBATE? M. DE SLOOVERE (1), L. HARLET (2), S. VAN STEENWEGHEN (3), E. MOREAU (1), D. DE SMET (1) (1) DEPARTMENT OF LABORATORY MEDICINE,
More informationThalassaemia and Abnormal Haemoglobins in Pregnancy
1. Purpose Thalassaemias and abnormal haemoglobins are detected in approximately 4% of patients of reproductive age attending the Women's. In almost half of these cases, the abnormality is not evident
More information